세계의 멸균 인디케이터 시장 : 시장 규모 분석(유형별, 방법별, 최종 용도별, 지역별)과 예측(2022-2032년)

The global sterility indicators market was valued at approximately USD 1.02 billion in 2023 and is expected to grow at a robust CAGR of 10.9% during the forecast period 2024-2032. This growth is driven by the increasing adoption of sterile practices across healthcare facilities and the growing need for infection control measures worldwide. As surgical procedures and hospital-acquired infections (HAIs) continue to rise, the demand for reliable sterilization processes and sterility assurance products has significantly increased.

Sterility indicators, comprising chemical and biological types, play a critical role in verifying the efficacy of sterilization methods, ensuring that medical devices, pharmaceutical products, and laboratory equipment remain free from microbial contamination. Regulatory bodies such as the FDA and EMA impose stringent sterilization standards, boosting the adoption of these indicators across healthcare and pharmaceutical industries. Moreover, technological advancements have enhanced the reliability, sensitivity, and ease of use of sterility indicators, further supporting their market expansion.

The hospital segment dominates the market owing to the high volume of sterilization requirements in surgical and general patient care settings. Simultaneously, the pharmaceutical sector is projected to register the fastest growth due to increasing R&D activities and regulatory mandates for sterility assurance in drug manufacturing. Regional growth is led by North America, driven by its advanced healthcare infrastructure and high infection control standards, while Asia Pacific emerges as the fastest-growing region due to expanding healthcare access and investments in sterilization technologies.

Major market players included in this report are:

• Getinge
• STERIS
• 3M
• Cardinal Health
• MATACHANA Group
• Mesa Labs, Inc.
• Andersen Sterilizers
• PMS Healthcare Technologies
• Propper Manufacturing Co., Inc.
• Liofilchem S.r.l.

The detailed segments and sub-segments of the market are explained below:

By Type:

• Chemical Indicators
  • Class 1
  • Class 2
  • Class 3
  • Class 4
  • Class 5
• Biological Indicators
  • Spore Ampoules
  • Spore Suspensions
  • Self-contained Vials
  • Spore Strips

By Technique:

• Heat Sterilization
• Low-Temperature Sterilization
• Filtration Sterilization
• Radiation Sterilization
• Liquid Sterilization

By End Use:

• Hospitals
• Pharmaceutical Companies
• Medical Device Companies
• Clinical Laboratories/Research Centers
• Others

By Region:

• North America
• U.S.
• Canada
• Mexico
• Europe
• UK
• Germany
• France
• Italy
• Spain
• Denmark
• Sweden
• Norway
• Asia Pacific
• Japan
• China
• India
• Australia
• South Korea
• Thailand
• Latin America
• Brazil
• Argentina
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE
• Kuwait

Years considered for the study are as follows:

• Historical Year: 2022
• Base Year: 2023
• Forecast Period: 2024 to 2032

Key Takeaways:

• Market Estimates & Forecasts for 10 years from 2022 to 2032.
• Annualized revenues and regional-level analysis for each market segment.
• Detailed analysis of the geographical landscape with country-level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations for future market approaches.
• Analysis of the competitive structure of the market.
• Demand-side and supply-side analysis of the market.

Table of Contents

Chapter 1. Global Sterility Indicators Market Executive Summary

• 1.1. Global Sterility Indicators Market Size & Forecast (2022-2032)
• 1.2. Regional Summary
• 1.3. Segmental Summary
  • 1.3.1. By Type
  • 1.3.2. By Technique
  • 1.3.3. By End Use
• 1.4. Key Trends
• 1.5. Recession Impact
• 1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Sterility Indicators Market Definition and Research Assumptions

• 2.1. Research Objective
• 2.2. Market Definition
• 2.3. Research Assumptions
  • 2.3.1. Inclusion & Exclusion
  • 2.3.2. Limitations
  • 2.3.3. Supply Side Analysis
    • 2.3.3.1. Availability
    • 2.3.3.2. Infrastructure
    • 2.3.3.3. Regulatory Environment
    • 2.3.3.4. Market Competition
    • 2.3.3.5. Economic Viability (Consumer's Perspective)
  • 2.3.4. Demand Side Analysis
    • 2.3.4.1. Regulatory Frameworks
    • 2.3.4.2. Technological Advancements
    • 2.3.4.3. Environmental Considerations
    • 2.3.4.4. Consumer Awareness & Acceptance
• 2.4. Estimation Methodology
• 2.5. Years Considered for the Study
• 2.6. Currency Conversion Rates

Chapter 3. Global Sterility Indicators Market Dynamics

• 3.1. Market Drivers
  • 3.1.1. Rising Prevalence of Healthcare-Associated Infections (HAIs)
  • 3.1.2. Increasing Surgical Procedures and Use of Medical Devices
  • 3.1.3. Stringent Regulatory Requirements for Sterilization Processes
• 3.2. Market Challenges
  • 3.2.1. High Costs Associated with Advanced Sterilization Techniques
  • 3.2.2. Limitations in Adopting Technology in Developing Regions
• 3.3. Market Opportunities
  • 3.3.1. Technological Innovations in Sterility Indicators
  • 3.3.2. Growing Demand in Emerging Markets
  • 3.3.3. Expanding Healthcare Infrastructure

Chapter 4. Global Sterility Indicators Market Industry Analysis

• 4.1. Porter's Five Forces Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
  • 4.1.6. Porter's Five Forces Impact Analysis
• 4.2. PESTEL Analysis
  • 4.2.1. Political
  • 4.2.2. Economical
  • 4.2.3. Social
  • 4.2.4. Technological
  • 4.2.5. Environmental
  • 4.2.6. Legal
• 4.3. Top Investment Opportunities
• 4.4. Top Winning Strategies
• 4.5. Disruptive Trends
• 4.6. Industry Expert Perspective
• 4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Sterility Indicators Market Size & Forecasts by Type (2022-2032)

• 5.1. Segment Dashboard
• 5.2. Global Sterility Indicators Market: By Type Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
  • 5.2.1. Chemical Indicators
    • 5.2.1.1. Class 1
    • 5.2.1.2. Class 2
    • 5.2.1.3. Class 3
    • 5.2.1.4. Class 4
    • 5.2.1.5. Class 5
  • 5.2.2. Biological Indicators
    • 5.2.2.1. Spore Ampoules
    • 5.2.2.2. Spore Suspensions
    • 5.2.2.3. Self-Contained Vials
    • 5.2.2.4. Spore Strips

Chapter 6. Global Sterility Indicators Market Size & Forecasts by Technique (2022-2032)

• 6.1. Segment Dashboard
• 6.2. Global Sterility Indicators Market: By Technique Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
  • 6.2.1. Heat Sterilization
  • 6.2.2. Low-Temperature Sterilization
  • 6.2.3. Filtration Sterilization
  • 6.2.4. Radiation Sterilization
  • 6.2.5. Liquid Sterilization

Chapter 7. Global Sterility Indicators Market Size & Forecasts by End Use (2022-2032)

• 7.1. Segment Dashboard
• 7.2. Global Sterility Indicators Market: By End Use Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
  • 7.2.1. Hospitals
  • 7.2.2. Pharmaceutical Companies
  • 7.2.3. Medical Device Companies
  • 7.2.4. Clinical Laboratories/Research Centers
  • 7.2.5. Others

Chapter 8. Global Sterility Indicators Market Size & Forecasts by Region (2022-2032)

• 8.1. North America Sterility Indicators Market
  • 8.1.1. U.S.
  • 8.1.2. Canada
  • 8.1.3. Mexico
• 8.2. Europe Sterility Indicators Market
  • 8.2.1. U.K.
  • 8.2.2. Germany
  • 8.2.3. France
  • 8.2.4. Italy
  • 8.2.5. Spain
  • 8.2.6. Denmark
  • 8.2.7. Sweden
  • 8.2.8. Norway
• 8.3. Asia Pacific Sterility Indicators Market
  • 8.3.1. Japan
  • 8.3.2. China
  • 8.3.3. India
  • 8.3.4. Australia
  • 8.3.5. South Korea
  • 8.3.6. Thailand
• 8.4. Latin America Sterility Indicators Market
  • 8.4.1. Brazil
  • 8.4.2. Argentina
• 8.5. Middle East & Africa (MEA) Sterility Indicators Market
  • 8.5.1. South Africa
  • 8.5.2. Saudi Arabia
  • 8.5.3. UAE
  • 8.5.4. Kuwait

Chapter 9. Competitive Intelligence

• 9.1. Key Company SWOT Analysis
  • 9.1.1. Getinge
  • 9.1.2. STERIS
  • 9.1.3. 3M
• 9.2. Top Market Strategies
• 9.3. Company Profiles
  • 9.3.1. Getinge
  • 9.3.2. STERIS
  • 9.3.3. 3M
  • 9.3.4. Cardinal Health
  • 9.3.5. MATACHANA Group
  • 9.3.6. Mesa Labs, Inc.
  • 9.3.7. Andersen Sterilizers
  • 9.3.8. PMS Healthcare Technologies
  • 9.3.9. Propper Manufacturing Co., Inc.
  • 9.3.10. Liofilchem S.r.l.

Chapter 10. Research Process

• 10.1. Research Process
  • 10.1.1. Data Mining
  • 10.1.2. Analysis
  • 10.1.3. Market Estimation
  • 10.1.4. Validation
  • 10.1.5. Publishing
• 10.2. Research Attributes